About this medicine
- Approved name
- Lemtrada
- International non-proprietary name (INN) or common name
- alemtuzumab
- Associated names
- Lemtrada
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-20/1483/C/3718/0028
- Type
- Article 20 procedures
This type of procedure is triggered for medicines that have been authorised via the centralised procedure in case of quality, safety or efficacy issues.
- Authorisation model
- Centrally authorised product(s)
- Decision making model
- PRAC-CHMP-EC
Key dates and outcomes
- Procedure start date
- 11/04/2019
- PRAC recommendation date
- 31/10/2019
- CHMP opinion date
- 14/11/2019
- EC decision date
- 16/01/2020
- Outcome
- Risk minimisation measures